Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice

Endocrinology

Volumn 150, Issue 11, 2009, Pages 4823-4834

  Ota, Norikazu ^a   Takaishi, Hironari ^a   Kosaki, Naoto ^a   Takito, Jiro ^a   Yoda, Masaki ^a   Tohmonda, Takahide ^a   Kimura, Tokuhiro ^a   Okada, Yasunori ^a   Yasuda, Hisataka ^b   Kawaguchi, Hiroshi ^c   Matsumoto, Morio ^a   Chiba, Kazuhiro ^a   Ikegami, Hiroyasu ^a   Toyama, Yoshiaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b Oriental Yeast Co Ltd   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITRIOL; INTERLEUKIN 1ALPHA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CALLUS; CARTILAGE CELL; CELL DIFFERENTIATION; CELL JUNCTION; CHONDROLYSIS; CONTROLLED STUDY; FRACTURE HEALING; KIDNEY CAPSULE; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TURNOVER TIME; WILD TYPE;

ANIMALS; CARTILAGE; CELL LINE; CELLS, CULTURED; CHONDROCYTES; FEMALE; FRACTURE HEALING; FRACTURES, BONE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPROTEGERIN; RANK LIGAND;

EID: 70350319526     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0452     Document Type: Article

References (59)

1. Karsenty G, Wagner EF 2002 Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389-406 (Pubitemid 34436569)
2. Ferguson C, Alpern E, Miclau T, Helms JA 1999 Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57-66
3. Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, Gerstenfeld LC, Einhorn TA 2001 Expression of osteoprotegerin, receptor activator of NF-κB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004-1014 (Pubitemid 32467144)
4. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA 2003 Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873-884
5. Dimitriou R, Tsiridis E, Giannoudis PV 2005 Current concepts of molecular aspects of bone healing. Injury 36:1392-1404 (Pubitemid 41618169)
6. Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA 2008 Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87:107-118
7. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z 1998 MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422 (Pubitemid 28232085)
8. Colnot C, Thompson Z, Miclau T, Werb Z, Helms JA 2003 Altered fracture repair in the absence of MMP9. Development 130:4123-4133 (Pubitemid 37063429)
9. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z 2004 Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131:5883-5895 (Pubitemid 40123905)
10. Kosaki N, Takaishi H, Kamekura S, Kimura T, Okada Y, Minqi L, Amizuka N, Chung UI, Nakamura K, Kawaguchi H, Toyama Y, D'Armiento J 2007 Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem Biophys Res Commun 354:846-851 (Pubitemid 46216210)
11. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaissé JM2000 Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879-889
12. Sasaki T, Kim TW, Debari K, Nagamine H 1996 Cartilage-bone replacement in endochondral ossification of mandibular condylar heads in young beagle dogs. J Electron Microsc (Tokyo) 45:213-222 (Pubitemid 126632164)
13. Jemtland R, Lee K, Segre GV 1998 Heterogeneity among cells that express osteoclast-associated genes in developing bone. Endocrinology 139:340-349 (Pubitemid 28166327)
14. Nordahl J, Andersson G, Reinholt FP 1998 Chondroclasts and osteoclasts in bones of young rats: comparison of ultrastructural and functional features. Calcif Tissue Int 63:401-408 (Pubitemid 28476330)
15. Bettex-Galland M, Boillat C, Bettex M 1990 Chondroclasts in osteoneogenesis. Tissue Cell 22:93-100
16. Ash P, Loutit JF, Townsend KM 1980 Osteoclasts derived from haematopoietic stem cells. Nature 283:669-670 (Pubitemid 10099996)
17. Scheven BA, Visser JW, Nijweide PJ 1986 In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 321:79-81
18. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T 1990 Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260-7264 (Pubitemid 20325246)
19. Arai F, Miyamoto T, Ohneda O, Inada T, Sudo T, Brasel K, Miyata T, Anderson DM, Suda T 1999 Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J Exp Med 190:1741-1754 (Pubitemid 30013841)
20. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357 (Pubitemid 30649812)
21. Nagai M, Kyakumoto S, Sato N 2000 Cancer cells responsible for humoral hypercalcemia expressmRNAencoding a secreted form of ODF/TRANCE that induces osteoclast formation. Biochem Biophys Res Commun 269:532-536 (Pubitemid 30440335)
22. Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M 2005 MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 7:485-496 (Pubitemid 40719131)
23. Hikita A, Yana I, Wakeyama H, Nakamura M, Kadono Y, Oshima Y, Nakamura K, Seiki M, Tanaka S 2006 Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand. J Biol Chem 281:36846-36855 (Pubitemid 46049798)
24. Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H 2000 Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 275:768-775 (Pubitemid 30708235)
25. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S 2002 Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 347:175-184 (Pubitemid 34764821)
26. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319 (Pubitemid 27199902)
27. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G 2006 Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116:3150-3159 (Pubitemid 44878629)
28. Usui M, Xing L, Drissi H, Zuscik M, O'Keefe R, Chen D, Boyce BF 2008 Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J Bone Miner Res 23:314-325 (Pubitemid 351304662)
29. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ, Gillespie MT 1999 Localization of RANKL (receptor activator of NF κB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25:525-534 (Pubitemid 29469458)
30. Ikeda T, Utsuyama M, Hirokawa K 2001 Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J Bone Miner Res 16:1416-1425 (Pubitemid 32675193)
31. Sakakura Y, Tsuruga E, Irie K, Hosokawa Y, Nakamura H, Yajima T 2005 Immunolocalization of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice. J Anat 207:325-337 (Pubitemid 41479537)
32. Silvestrini G, Ballanti P, Patacchioli F, Leopizzi M, Gualtieri N, Monnazzi P, Tremante E, Sardella D, Bonucci E 2005 Detection of osteoprotegerin (OPG) and its ligand (RANKL)mRNAand protein in femur and tibia of the rat. J Mol Histol 36:59-67 (Pubitemid 40614383)
33. Kishimoto K, Kitazawa R, Kurosaka M, Maeda S, Kitazawa S 2006 Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage. Histochem Cell Biol 125:593-602 (Pubitemid 43673522)
34. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323 (Pubitemid 29061638)
35. Kim N, Odgren PR, Kim DK, Marks Jr SC, Choi Y 2000 Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Natl Acad Sci USA 97:10905-10910 (Pubitemid 30751252)
36. Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, Kinosaki M, Yamaguchi K, Tsuda E, Murakami A, Yasuda H, Higashio K 2002 Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J Bone Miner Metab 20:337-344 (Pubitemid 40645655)
37. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS 1998 osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268 (Pubitemid 28213402)
38. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H 1998 Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247:610-615 (Pubitemid 28418439)
39. Nakamura M, Udagawa N, Matsuura S, Mogi M, Nakamura H, Horiuchi H, Saito N, Hiraoka BY, Kobayashi Y, Takaoka K, Ozawa H, Miyazawa H, Takahashi N 2003 Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 144:5441-5449 (Pubitemid 37476073)
40. Kawana F, Sasaki T 2003 Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice. J Electron Microsc (Tokyo) 52:515-525 (Pubitemid 38092539)
41. Yamazaki H, Sasaki T 2005 Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin- deficient mice. J Electron Microsc (Tokyo) 54:467-477 (Pubitemid 43011846)
42. Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, Mizoguchi T, Sato M, Mogi M, Penninger JM, Takahashi N 2007 Osteoprotegerin reduces the serum level of receptor activator of NF-κB ligand derived from osteoblasts. J Immunol 178:192-200 (Pubitemid 46033601)
43. Min JK, Kim YM, Kim YM, Kim EC, Gho YS, Kang IJ, Lee SY, Kong YY, Kwon YG 2003 Vascular endothelial growth factor up-regulates expression of receptor activator of NF-κB (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. J Biol Chem 278:39548-39557
44. Flick LM, Weaver JM, Ulrich-Vinther M, Abuzzahab F, Zhang X, Dougall WC, Anderson D, O'Keefe RJ, Schwarz EM 2003 Effects of receptor activator of NFκB (RANK) signaling blockade on fracture healing. J Orthop Res 21:676-684 (Pubitemid 36758211)
45. Landry P, Sadasivan K, Marino A, Albright J 1997 Apoptosis is coordinately regulated with osteoblast formation during bone healing. Tissue Cell 29:413-419 (Pubitemid 27373098)
46. Lee FY, Choi YW, Behrens FF, DeFouw DO, Einhorn TA 1998 Programmed removal of chondrocytes during endochondral fracture healing. J Orthop Res 16:144-150
47. Olmedo ML, Landry PS, Sadasivan KK, Albright JA, Meek WD, Routh R, Marino AA 1999 Regulation of osteoblast levels during bone healing. J Orthop Trauma 13:356-362
48. Li G, White G, Connolly C, Marsh D 2002 Cell proliferation and apoptosis during fracture healing. J Bone Miner Res 17:791-799 (Pubitemid 34441895)
49. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG 1995 Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682 (Pubitemid 26091143)
50. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A 1996 Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690 (Pubitemid 26175834)
51. Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR 1998 Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363-14367 (Pubitemid 28319153)
52. Shimizu S, Asou Y, Itoh S, Chung UI, Kawaguchi H, Shinomiya K, Muneta T 2007 Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. Arthritis Rheum 56:3358-3365 (Pubitemid 47585430)
53. Amizuka N, Shimomura J, Li M, Seki Y, Oda K, Henderson JE, Mizuno A, Ozawa H, Maeda T 2003 Defective bone remodelling in osteoprotegerin-deficient mice. J Electron Microsc (Tokyo) 52:503-513 (Pubitemid 38092538)
54. Uchida S, Doi Y, Kudo H, Furukawa H, Nakamura T, Fujimoto S 2000 Transient expression of activin βA mRNA on osteoprogenitor cells in rat bone regeneration after drill-hole injury. Bone 27:81-90 (Pubitemid 30365081)
55. Uchida S, Sakai A, Kudo H, Otomo H, Watanuki M, Tanaka M, Nagashima M, Nakamura T 2003 Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32:491-501 (Pubitemid 39665708)
56. Tanaka M, Sakai A, Uchida S, Tanaka S, Nagashima M, Katayama T, Yamaguchi K, Nakamura T 2004 Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local up-regulation of bone turnover in mature rats. Bone 34:940-948 (Pubitemid 38749231)
57. Nagashima M, Sakai A, Uchida S, Tanaka S, Tanaka M, Nakamura T 2005 Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 36:502-511 (Pubitemid 40403848)
58. Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA 2009 Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res 24:196-208
59. Akiyama H, Shigeno C, Iyama K, Ito H, Hiraki Y, Konishi J, Nakamura T 1999 Indian hedgehog in the late-phase differentiation in mouse chondrogenic EC cells, ATDC5: upregulation of type X collagen and osteoprotegerin ligand mRNAs. Biochem Biophys Res Commun 257:814-820